3,14,19-Trihydroxycard-20(22)-enolide (Coroglaucigenin) (CHEM114213)
| Record Information | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Version | 1.0 | ||||||||
| Creation Date | 2026-04-06 01:21:29 UTC | ||||||||
| Update Date | 2026-05-21 00:34:25 UTC | ||||||||
| Accession Number | CHEM114213 | ||||||||
| Identification | |||||||||
| Common Name | 3,14,19-Trihydroxycard-20(22)-enolide (Coroglaucigenin) | ||||||||
| Class | Small Molecule | ||||||||
| Description | 3,14,19-Trihydroxycard-20(22)-enolide (Coroglaucigenin) belongs to the steroid lactones, a subclass of steroids and steroid derivatives within the organic compounds. This compound has the chemical formula C23H34O5 and an average molecular weight of 390.52 g/mol. The substance is found in or released from 13 recorded sources across several sectors. Within Electrical & Electronic Equipment, it is associated with capacitors, batteries, wires and cables, cell phones, printed circuit boards, and one additional source. In the Textiles, leather & furnishings sector, it is linked to synthetic textiles as well as carpets and rugs. It is also found in food packaging within the Food, food processing & cookware category. Additionally, it is present in medical devices from the Healthcare, pharmaceuticals & veterinary products sector, and in lubricants used in both Energy, oil & gas and Industrial manufacturing & chemical processing. One further sector is also recorded. Recorded exposure routes for this compound include oral, inhalation, and touch. | ||||||||
| Contaminant Sources | Not Available | ||||||||
| Contaminant Type |
| ||||||||
| Chemical Structure |  | ||||||||
| Synonyms | Not Available | ||||||||
| Chemical Formula | C23H34O5 | ||||||||
| Average Molecular Mass | 390.520 g/mol | ||||||||
| Monoisotopic Mass | 390.241 g/mol | ||||||||
| CAS Registry Number | 468-19-9 | ||||||||
| IUPAC Name | 3,14,19-Trihydroxycard-20(22)-enolide | ||||||||
| Traditional Name | Not Available | ||||||||
| SMILES | CC12CCC3C(CCC4CC(O)CCC34CO)C1(O)CCC2C1=CC(=O)OC1 | ||||||||
| InChI Identifier | InChI=1S/C23H34O5/c1-21-7-5-18-19(3-2-15-11-16(25)4-8-22(15,18)13-24)23(21,27)9-6-17(21)14-10-20(26)28-12-14/h10,15-19,24-25,27H,2-9,11-13H2,1H3 | ||||||||
| InChI Key | CDMVQQAHEQVSMF-UHFFFAOYSA-N | ||||||||
| Chemical Taxonomy | |||||||||
| Classification | Not classified | ||||||||
| Biological Properties | |||||||||
| Status | Detected and Not Quantified | ||||||||
| Origin | Not Available | ||||||||
| Cellular Locations | Not Available | ||||||||
| Biofluid Locations | Not Available | ||||||||
| Tissue Locations | Not Available | ||||||||
| Pathways | Not Available | ||||||||
| Applications | Not Available | ||||||||
| Biological Roles | Not Available | ||||||||
| Chemical Roles | Not Available | ||||||||
| Physical Properties | |||||||||
| State | Not Available | ||||||||
| Appearance | Not Available | ||||||||
| Experimental Properties |
| ||||||||
| Predicted Properties | Not Available | ||||||||
| Spectra | |||||||||
| Spectra |
| ||||||||
| Toxicity Profile | |||||||||
| Route of Exposure | Not Available | ||||||||
| Mechanism of Toxicity | Not Available | ||||||||
| Metabolism | Not Available | ||||||||
| Toxicity Values | Not Available | ||||||||
| Lethal Dose | Not Available | ||||||||
| Carcinogenicity (IARC Classification) | Not Available | ||||||||
| Uses/Sources | Not Available | ||||||||
| Minimum Risk Level | Not Available | ||||||||
| Health Effects | Not Available | ||||||||
| Symptoms | Not Available | ||||||||
| Treatment | Not Available | ||||||||
| Concentrations | |||||||||
| Not Available | |||||||||
| External Links | |||||||||
| Identifiers | Not Available | ||||||||
| References | |||||||||
| Synthesis Reference | Not Available | ||||||||
| MSDS | Not Available | ||||||||
| General References | Not Available | ||||||||
